Semaglutide and Kidney Stones: What the Evidence Shows

A kidney stone and kidney injury are different problems. Stones can cause pain or obstruct urine flow; acute kidney injury means a sudden decline in kidney function. If you have had stones before, tell your prescriber before starting semaglutide, and keep your existing stone-prevention plan under review. Neither a history of stones nor a reassuring urine test supplies a complete answer about treatment suitability.

Does the Wegovy label report kidney stones?

Yes. In its cardiovascular outcomes trial, the current Wegovy label reports urolithiasis in 1.2% of treated participants versus 0.8% receiving placebo. Serious events were reported in 0.6% versus 0.4%¹. These are proportions over the trial, not annual rates or a prediction of your personal risk.

The study enrolled adults aged 45 or older with established cardiovascular disease and overweight or obesity, without diabetes. Treatment targeted semaglutide 2.4 mg by weekly injection; participants could remain on a lower dose if necessary. Median follow-up was 41.8 months. Do not automatically transfer those numbers to every dose, oral formulation or patient population¹. The observed difference deserves attention, but it does not identify a single cause of each stone.

The broader gallbladder and kidney guide separates these organ concerns. Gallstones occur in the biliary system; they are not kidney stones.

What did the stone-former study actually find?

A retrospective study followed 44 people with obesity and a history of kidney stones receiving GLP-1-based weight-loss treatments. Over a median 1.1 years, average weight fell by 6.6 kg. Urinary oxalate decreased, while several other urine measurements and calculated supersaturation measures did not change significantly².

This is useful preliminary information about urine chemistry. It was a small observational study involving several treatments, rather than a randomized semaglutide-only trial. It did not establish that treatment prevents recurrent stones. A change in one urine ingredient is not the same outcome as fewer painful episodes, procedures or obstructions.

How do dehydration and kidney benefits fit in?

The label separately warns about acute kidney injury due to volume depletion. Most reported postmarketing cases occurred with gastrointestinal reactions leading to dehydration¹. That warning does not mean all kidney symptoms are dehydration or that extra water prevents every event. Our semaglutide and dehydration guide explains when fluid loss needs assessment.

Likewise, evidence supporting Ozempic for diabetic kidney disease addresses a different population and outcome. Long-term kidney benefits do not demonstrate stone prevention or cancel the need to assess new pain.

What should a stone-prevention plan include?

NIDDK advises tailoring prevention to the kind of stone. Sodium, animal protein, dietary calcium and oxalate can matter differently depending on stone type. Do not broadly eliminate calcium or start a restrictive diet based on a suspected stone⁴. Bring prior stone analyses and 24-hour urine results to your appointment if available.

Ask for a fluid goal that fits your health. NIDDK’s general drinking advice includes an exception for kidney failure⁴. If you already have a fluid restriction or another condition affecting fluid balance, follow your care team’s instructions. There is no universal water target in this guide.

If appetite falls substantially, discuss how to meet nutrition needs while respecting stone advice. Generic protein advice during semaglutide treatment cannot replace a stone-specific diet plan. Ask before adding concentrated supplements or making large dietary changes.

Which symptoms need prompt attention?

Sharp pain in the back, side, lower abdomen or groin, blood in the urine, painful urination or difficulty passing urine can occur with stones. NIDDK advises seeing a health professional right away for stone symptoms³. Fever or chills with pain, inability to urinate, or persistent vomiting needs urgent assessment; do not assume this is a routine medication side effect.

Frequent urination also has several possible explanations. Symptoms alone cannot confirm a stone. Tell the clinician your exact semaglutide product, recent dose changes, symptoms, other medicines and stone history. Ask what evaluation is needed and how to handle the next dose if you are unwell; do not change treatment from a general article.